1. Home
  2. GNLX vs ARQQ Comparison

GNLX vs ARQQ Comparison

Compare GNLX & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • ARQQ
  • Stock Information
  • Founded
  • GNLX 2001
  • ARQQ 2017
  • Country
  • GNLX United States
  • ARQQ United Kingdom
  • Employees
  • GNLX N/A
  • ARQQ N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • ARQQ Computer Software: Prepackaged Software
  • Sector
  • GNLX Health Care
  • ARQQ Technology
  • Exchange
  • GNLX Nasdaq
  • ARQQ Nasdaq
  • Market Cap
  • GNLX 184.4M
  • ARQQ 173.1M
  • IPO Year
  • GNLX 2023
  • ARQQ N/A
  • Fundamental
  • Price
  • GNLX $2.60
  • ARQQ $13.42
  • Analyst Decision
  • GNLX Strong Buy
  • ARQQ Strong Buy
  • Analyst Count
  • GNLX 4
  • ARQQ 1
  • Target Price
  • GNLX $18.25
  • ARQQ $52.00
  • AVG Volume (30 Days)
  • GNLX 161.3K
  • ARQQ 543.7K
  • Earning Date
  • GNLX 03-28-2025
  • ARQQ 05-19-2025
  • Dividend Yield
  • GNLX N/A
  • ARQQ N/A
  • EPS Growth
  • GNLX N/A
  • ARQQ N/A
  • EPS
  • GNLX N/A
  • ARQQ N/A
  • Revenue
  • GNLX $8,000.00
  • ARQQ $293,000.00
  • Revenue This Year
  • GNLX N/A
  • ARQQ $1,818.77
  • Revenue Next Year
  • GNLX N/A
  • ARQQ N/A
  • P/E Ratio
  • GNLX N/A
  • ARQQ N/A
  • Revenue Growth
  • GNLX N/A
  • ARQQ N/A
  • 52 Week Low
  • GNLX $1.60
  • ARQQ $3.72
  • 52 Week High
  • GNLX $5.89
  • ARQQ $52.79
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 30.97
  • ARQQ 41.39
  • Support Level
  • GNLX $3.03
  • ARQQ $16.50
  • Resistance Level
  • GNLX $3.35
  • ARQQ $20.70
  • Average True Range (ATR)
  • GNLX 0.37
  • ARQQ 2.53
  • MACD
  • GNLX -0.12
  • ARQQ -0.20
  • Stochastic Oscillator
  • GNLX 4.92
  • ARQQ 8.08

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.

Share on Social Networks: